Spatial heterogeneity of nanomedicine investigated by multiscale imaging of the drug, the nanoparticle and the tumour environment

Keyphrases

• Nanoparticles 100%
• Nanomedicine 100%
• Spatial Heterogeneity 100%
• Tumor Environment 100%
• Multiscale Imaging 100%
• Nanoparticle Distribution 60%
• Imaging Modalities 40%
• Tumor Heterogeneity 40%
• Drug Distribution 40%
• InP Nanoparticles 40%
• Nanotherapy 40%
• In Cancer 20%
• Drug Efficacy 20%
• Tumor 20%
• Inter-patient 20%
• Imaging Techniques 20%
• Cancer Treatment 20%
• Treatment Effect 20%
• Patient Selection 20%
• Ultrasound 20%
• Clinical Efficacy 20%
• Optical Imaging 20%
• Preclinical Imaging 20%
• Choosing Wisely 20%
• Mass Spectrometry Imaging 20%
• Nuclear Imaging 20%
• Drug Safety 20%
• Therapy Resistance 20%
• Targeted Drugs 20%
• Intratumor 20%
• Cellular Scale 20%
• Heterogeneous Distribution 20%
• Imaging Spectrometry 20%
• Spatially Heterogeneous 20%
• Nanoparticle Imaging 20%
• Pseudoresistance 20%
• Drug Nanoparticles 20%
• Drug Environment 20%
• Payload Distribution 20%
• Spatial Drug Distribution 20%
• Heterogeneous Treatment Effects 20%
• CT-like MRI 20%
• Nanoparticle Drugs 20%

Medicine and Dentistry

• Nanomedicine 100%
• Tumor 100%
• Nanoparticle 100%
• Drug Distribution 50%
• Tumour Heterogeneity 33%
• Magnetic Resonance Imaging 16%
• Cancer Therapy 16%
• Patient Selection 16%
• Weakness 16%
• Treatment Effect 16%
• Optical Imaging 16%
• Clinical Imaging 16%
• Therapy Resistance 16%
• Nuclear Imaging 16%
• Mass Spectrometry Imaging 16%
• Genetics 16%
• Drug Targeting 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Nanoparticle 100%
• Nanomedicine 100%
• Drug Distribution 50%
• Malignant Neoplasm 16%
• Weakness 16%
• Drug Delivery System 16%
• Therapy Resistance 16%
• Optical Imaging 16%